Physician profile
Lee C Raley
NPI 1730297979
$5,913.02
in general payments reported to CMS, 2019-2025
27 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,918 · 2020: $156 · 2021: $175 · 2022: $183 · 2023: $159 · 2024: $155 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,789.88 | 2019-2024 | |
| Smith+Nephew, INC. | $174.89 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home |
| Merck Sharp & Dohme LLC | $145.12 | 2019-2022 | |
| Davol INC. | $109.63 | 2023 | Arista Ah Flexitip |
| Ethicon US, LLC | $97.81 | 2019-2025 | Stratafix, Prolene |
| Innovation Technologies INC | $83.32 | 2022-2025 | Irrisept |
| Zyla Life Sciences, INC. | $51.28 | 2019 | |
| Medtronic USA, INC. | $43.15 | 2020 | |
| Baudax Bio INC. | $38.38 | 2021 | |
| Medline Industries LP | $33.25 | 2019 | |
| Medtronic, INC. | $31.58 | 2021-2023 | Signia |
| Takeda Pharmaceuticals U.S.A., INC. | $29.46 | 2021-2023 | Gattex |
| Polynovo North America LLC | $28.73 | 2022 | |
| Edwards Lifesciences Corporation | $27.30 | 2024 | Hemosphere |
| Teleflex LLC | $25.80 | 2024 | Quikclot |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $22.31 | 2022 | |
| Mauna Kea Technologies, INC. | $21.21 | 2021 | |
| Myriad Genetic Laboratories, INC. | $20.47 | 2025 | Myrisk |
| Abbvie INC. | $20.04 | 2025 | |
| Solventum Corporation | $18.67 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, Abthera |
| Micro-Tech Endoscopy USA, INC. | $17.93 | 2025 | |
| W. L. Gore & Associates, INC. | $16.34 | 2025 | Gore Enform Intraperitoneal Biomaterial |
| Acell, INC. | $15.75 | 2020 | |
| Kci USA, INC. | $15.66 | 2022 | |
| Conmed Corporation | $14.06 | 2019 | |
| Boston Scientific Corporation | $13.09 | 2022 | |
| Bolder Surgical LLC | $7.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Raley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.